← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

LQDA logoLiquidia Corporation(LQDA)Earnings, Financials & Key Ratios

LQDA•NASDAQ
$42.14
$3.66B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutLiquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Show more
  • Revenue$14M-20.0%
  • EBITDA-$119M-67.3%
  • Net Income-$130M-66.1%
  • EPS (Diluted)-1.66-37.2%
  • Gross Margin58%-30.5%
  • EBITDA Margin-850.94%-109.0%
  • Operating Margin-866.63%-106.5%
  • Net Margin-931.65%-107.5%
  • ROE-209.35%-83.6%
  • ROIC-500.72%-58.1%
  • Debt/Equity1.58+51.2%
  • Interest Coverage-9.71+17.0%
Technical→

LQDA Key Insights

Liquidia Corporation (LQDA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 85 (top 15%)
  • ✓Strong 5Y sales CAGR of 11.6%

✗Weaknesses

  • ✗Weak Piotroski F-Score: 1/9
  • ✗Negative free cash flow
  • ✗Shares diluted 21.1% in last year
  • ✗Expensive at 42.9x book value
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

LQDA Price & Volume

Liquidia Corporation (LQDA) stock price & volume — 10-year historical chart

Loading chart...

LQDA Growth Metrics

Liquidia Corporation (LQDA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years11.64%
3 Years2.88%
TTM343.41%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-1.99%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM10.57%

Return on Capital

10 Years-97.97%
5 Years-62.33%
3 Years-62.76%
Last Year-84.14%

LQDA Recent Earnings

Liquidia Corporation (LQDA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
Mar 5, 2026
EPS
$0.15
Est $0.08
+87.5%
Revenue
$92M
Est $89M
+3.9%
Q4 2025
Nov 3, 2025
EPS
$0.04
Est $0.45
+91.1%
Revenue
$54M
Est $81M
-32.7%
Q3 2025
Aug 12, 2025
EPS
$0.49
Est $0.43
-14.0%
Revenue
$9M
Est $14M
-38.2%
Q2 2025
May 8, 2025
EPS
$0.45
Est $0.42
-7.1%
Revenue
$3M
Est $4M
-25.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 5, 2026
$0.15vs $0.08+87.5%
$92Mvs $89M+3.9%
Q4 2025Nov 3, 2025
$0.04vs $0.45+91.1%
$54Mvs $81M-32.7%
Q3 2025Aug 12, 2025
$0.49vs $0.43-14.0%
$9Mvs $14M-38.2%
Q2 2025May 8, 2025
$0.45vs $0.42-7.1%
$3Mvs $4M-25.0%
Based on last 12 quarters of dataView full earnings history →

LQDA Peer Comparison

Liquidia Corporation (LQDA) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
UTHR logoUTHRUnited Therapeutics CorporationDirect Competitor26.13B596.1321.4010.61%40.61%19.24%
MNKD logoMNKDMannKind CorporationDirect Competitor1.1B3.5617822.23%-6.63%
INVA logoINVAInnoviva, Inc.Direct Competitor1.91B22.526.8218.52%118.91%46.47%0.23
PRAX logoPRAXPraxis Precision Medicines, Inc.Direct Competitor7.61B337.95-25.07-100%-58.74%0.00
INSM logoINSMInsmed IncorporatedProduct Competitor29.14B137.09-21.3566.73%-264.83%-125.2%0.06
NKTR logoNKTRNektar TherapeuticsProduct Competitor1.67B85.09-8.75-43.89%-192.87%-356.81%0.95
PBYI logoPBYIPuma Biotechnology, Inc.Product Competitor379.14M7.4512.21-0.91%13.6%27.78%0.22
KALA logoKALAKALA BIO, Inc.Product Competitor855.53K0.12-0.02-141.11%-388.29%2.62

Compare LQDA vs Peers

Liquidia Corporation (LQDA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs UTHR

Most directly comparable listed peer for LQDA.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare LQDA against a more recognizable public peer.

Peer Set

Compare Top 5

vs UTHR, MNKD, INVA, PRAX

LQDA Income Statement

Liquidia Corporation (LQDA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue13.22M7.26M2.71M8.07M739.63K12.85M15.94M17.49M14M69.22M
Revenue Growth %--45.08%-62.7%198.2%-90.84%1637.77%23.98%9.75%-19.97%343.41%
Cost of Goods Sold918.78K319.76K121.39K807.19K237.71K3.02M2.86M2.89M5.88M7.34M
COGS % of Revenue6.95%4.41%4.48%10%32.14%23.52%17.94%16.51%42%-
Gross Profit
12.3M▲ 0%
6.94M▼ 43.6%
2.59M▼ 62.7%
7.26M▲ 181.0%
501.92K▼ 93.1%
9.83M▲ 1858.5%
13.08M▲ 33.0%
14.6M▲ 11.7%
8.12M▼ 44.4%
61.88M▲ 0%
Gross Margin %93.05%95.59%95.52%90%67.86%76.48%82.06%83.49%58%89.4%
Gross Profit Growth %--43.58%-62.73%180.98%-93.09%1858.49%33.02%11.65%-44.4%-
Operating Expenses28.16M34.97M37.45M54.09M59.59M43.63M51.85M87.98M129.41M169.15M
OpEx % of Revenue213.07%481.76%1383.6%670.07%8056.89%339.43%325.36%503.11%924.63%-
Selling, General & Admin4.84M10.21M8.75M13.6M27.37M23.11M32.41M44.74M81.57M130.14M
SG&A % of Revenue36.63%140.71%323.39%168.45%3700.33%179.8%203.39%255.84%582.8%-
Research & Development23.32M24.75M28.7M40.49M32.22M20.52M19.43M43.24M47.84M38.81M
R&D % of Revenue176.44%341.05%1060.21%501.62%4356.57%159.63%121.96%247.27%341.83%-
Other Operating Expenses000000000205K
Operating Income
-15.86M▲ 0%
-28.03M▼ 76.7%
-34.87M▼ 24.4%
-46.82M▼ 34.3%
-59.09M▼ 26.2%
-33.8M▲ 42.8%
-38.77M▼ 14.7%
-73.38M▼ 89.3%
-121.29M▼ 65.3%
-107.27M▲ 0%
Operating Margin %-120.02%-386.16%-1288.08%-580.07%-7989.03%-262.95%-243.3%-419.62%-866.63%-154.98%
Operating Income Growth %--76.69%-24.4%-34.29%-26.2%42.8%-14.71%-89.28%-65.29%-
EBITDA-15.21M-27.1M-33.32M-44.03M-55.97M-28.18M-35.12M-71.21M-119.1M-105.54M
EBITDA Margin %-115.09%-373.32%-1231.05%-545.46%-7567.72%-219.29%-220.41%-407.17%-850.94%-152.49%
EBITDA Growth %--78.13%-22.98%-32.13%-27.12%49.65%-24.62%-102.73%-67.26%3.56%
D&A (Non-Cash Add-back)651.56K931.93K1.54M2.79M3.12M5.61M3.65M2.18M2.2M1.73M
EBIT-15.85M-16.14M-34.15M-46.21M-58.9M-33.82M-38.68M-72.23M-117.91M-100.21M
Net Interest Income-70.96K-13.01M-18.68M-759.91K-673.64K-729K-1.25M-2.81M-4.83M-14.58M
Interest Income14.91K268304.98K613.72K184.36K33K1.09M3.47M7.65M7.06M
Interest Expense85.86K13.01M18.99M1.37M858K762K2.34M6.27M12.49M21.64M
Other Income/Expense-70.96K-1.13M-18.27M-759.91K-673.64K-782K-2.25M-5.12M-9.1M-14.58M
Pretax Income
-15.93M▲ 0%
-29.15M▼ 83.0%
-53.14M▼ 82.3%
-47.58M▲ 10.4%
-59.76M▼ 25.6%
-34.58M▲ 42.1%
-41.02M▼ 18.6%
-78.5M▼ 91.4%
-130.39M▼ 66.1%
-121.85M▲ 0%
Pretax Margin %-120.56%-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-176.04%
Income Tax14.91K000000000
Effective Tax Rate %-0.09%0%0%0%0%0%0%0%0%0%
Net Income
-15.93M▲ 0%
-29.15M▼ 83.0%
-53.14M▼ 82.3%
-47.58M▲ 10.4%
-59.76M▼ 25.6%
-34.58M▲ 42.1%
-41.02M▼ 18.6%
-78.5M▼ 91.4%
-130.39M▼ 66.1%
-121.85M▲ 0%
Net Margin %-120.56%-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-176.04%
Net Income Growth %--82.97%-82.26%10.45%-25.6%42.14%-18.61%-91.4%-66.1%-1.99%
Net Income (Continuing)-15.93M-29.15M-53.14M-47.58M-59.76M-34.58M-41.02M-78.5M-130.39M-121.85M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-1.86▲ 0%
-3.40▼ 82.8%
-7.42▼ 118.2%
-2.51▲ 66.2%
-1.76▲ 29.9%
-0.70▲ 60.2%
-0.67▲ 4.3%
-1.21▼ 80.6%
-1.66▼ 37.2%
-1.41▲ 0%
EPS Growth %--82.8%-118.24%66.17%29.88%60.23%4.29%-80.6%-37.19%10.57%
EPS (Basic)-1.86-3.40-7.42-2.51-1.76-0.70-0.67-1.21-1.66-
Diluted Shares Outstanding8.59M8.59M7.16M18.48M33.89M49.68M60.96M64.99M78.71M86.33M
Basic Shares Outstanding8.59M8.59M7.16M18.48M33.89M49.68M60.96M64.99M78.71M86.33M
Dividend Payout Ratio----------

LQDA Balance Sheet

Liquidia Corporation (LQDA) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets3.15M5.48M40.03M56.39M66.07M61.28M99.81M89.9M185.1M226.72M
Cash & Short-Term Investments1.44M3.42M39.53M55.8M65.32M57.49M93.28M83.68M176.48M157.5M
Cash Only1.44M3.42M39.53M55.8M65.32M57.49M93.28M83.68M176.48M157.5M
Short-Term Investments0000000000
Accounts Receivable1.24M1.62M272.56K002.99M5.02M4.06M2.72M35.96M
Days Sales Outstanding34.2181.5836.75--84.91114.9284.7670.9165.78
Inventory00000000241K24.53M
Days Inventory Outstanding--------14.96405.1
Other Current Assets00000-3811.51M2.16M5.67M8.73M
Total Non-Current Assets5.34M9.36M9.39M12.46M33.46M32.45M29.39M28.43M45.21M49.26M
Property, Plant & Equipment4.35M8.24M8.13M12.08M9.45M7.43M6.25M6.18M12.48M14.72M
Fixed Asset Turnover3.04x0.88x0.33x0.67x0.08x1.73x2.55x2.83x1.12x5.18x
Goodwill00003.9M3.9M3.9M3.9M3.9M3.9M
Intangible Assets00005.53M4.39M3.73M3.43M3.16M2.99M
Long-Term Investments0000000003.5M
Other Non-Current Assets992.72K1.12M1.26M378.04K14.57M16.73M15.51M14.92M25.66M121.67M
Total Assets
8.49M▲ 0%
14.84M▲ 74.9%
49.42M▲ 232.9%
68.84M▲ 39.3%
99.53M▲ 44.6%
93.73M▼ 5.8%
129.2M▲ 37.8%
118.33M▼ 8.4%
230.31M▲ 94.6%
275.98M▲ 0%
Asset Turnover1.56x0.49x0.05x0.12x0.01x0.14x0.12x0.15x0.06x0.28x
Asset Growth %-74.91%232.93%39.3%44.58%-5.83%37.84%-8.41%94.63%164.28%
Total Current Liabilities12.09M30.52M8.25M16.87M11.74M7.33M8.8M18.55M41.78M102.94M
Accounts Payable2.41M4.42M3.24M3.5M3.73M1.07M2.2M1.4M4.69M6.02M
Days Payables Outstanding956.325.05K9.73K1.58K5.73K129.19280.48176.43291.12382.23
Short-Term Debt2.9M15.61M316.91K5.59M0002.62M18.02M56.48M
Deferred Revenue (Current)3.34M3.61M8.07B0000000
Other Current Liabilities1.16M2.22M268.6K1.29M5.03M3.16M2.86M8.54M18.66M31.27M
Current Ratio0.26x0.18x4.85x3.34x5.63x8.36x11.34x4.85x4.43x4.43x
Quick Ratio0.26x0.18x4.85x3.34x5.63x8.36x11.34x4.85x4.42x4.42x
Cash Conversion Cycle---------205.2588.65
Total Non-Current Liabilities14.64M18.01M22.48M17.02M16.71M21.14M29.98M52.49M111.26M150.99M
Long-Term Debt5.22M5.56M11.63M10.29M10.29M10.41M19.88M43.42M97.37M136.45M
Capital Lease Obligations243.43K510.63K376.08K6.73M5.26M4.58M3.5M2.36M6.59M25.7M
Deferred Tax Liabilities-243.43K-510.63K-376.08K0000000
Other Non-Current Liabilities456.9K6.42M2.41M01.15M6.14M6.59M6.71M7.3M31.09M
Total Liabilities26.73M48.54M30.73M33.89M28.45M28.46M38.78M71.04M153.04M253.93M
Total Debt8.68M22.15M12.77M24.42M17.14M16.08M24.46M49.54M122.39M199.18M
Net Debt7.24M18.73M-26.76M-31.38M-48.17M-41.41M-68.82M-34.14M-54.09M41.69M
Debt / Equity--0.68x0.70x0.24x0.25x0.27x1.05x1.58x1.58x
Debt / EBITDA----------1.89x
Net Debt / EBITDA----------0.39x
Interest Coverage-184.74x-2.15x-1.84x-34.09x-68.87x-44.35x-16.58x-11.70x-9.71x-4.63x
Total Equity
-18.25M▲ 0%
-33.69M▼ 84.7%
18.69M▲ 155.5%
34.95M▲ 87.0%
71.09M▲ 103.4%
65.27M▼ 8.2%
90.42M▲ 38.5%
47.29M▼ 47.7%
77.28M▲ 63.4%
22.05M▲ 0%
Equity Growth %--84.66%155.47%87.01%103.41%-8.19%38.55%-47.7%63.4%-134.8%
Book Value per Share-2.12-3.922.611.892.101.311.480.730.980.26
Total Shareholders' Equity-18.25M-33.69M18.69M34.95M71.09M65.27M90.42M47.29M77.28M22.05M
Common Stock55457015.52K28.23K43.34K52K64K69K85K87K
Retained Earnings-84.26M-113.41M-167.05M-215.24M-275M-309.58M-350.6M-429.1M-559.49M-640.87M
Treasury Stock0000000000
Accumulated OCI-6.87M-7.8M-9.3M0000000
Minority Interest0000000000

LQDA Cash Flow Statement

Liquidia Corporation (LQDA) cash flow — operating, investing & free cash flow history

Line itemDec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-13.95M-24.29M-31.83M-48.28M-54.14M-34.03M-28.59M-41.56M-93.42M-93.42M
Operating CF Margin %-105.52%-334.66%-1175.87%-598.14%-7320.51%-264.8%-179.4%-237.67%-667.49%-
Operating CF Growth %--74.17%-31.04%-51.69%-12.14%37.14%16%-45.39%-124.77%-66.78%
Net Income-15.93M-29.15M-53.14M-47.58M-59.76M-34.58M-41.02M-78.5M-130.39M-121.85M
Depreciation & Amortization651.56K931.93K1.54M2.57M3.13M5.61M3.65M2.18M2.2M1.73M
Stock-Based Compensation347.44K514.09K2.2M3.38M3.95M6.75M9.3M10.09M18.81M27.3M
Deferred Taxes0-11.88M-415.41K6.59K10.8K00000
Other Non-Cash Items391.65K14.91M17.69M300.9K235.53K566K1.64M18.8M20.76M25.46M
Working Capital Changes596.41K389.67K294.85K-6.95M-1.71M-12.38M-2.16M5.87M-4.79M-33.38M
Change in Receivables2.53M-328.46K1.35B272.56K0-2.99M-2.03M956K1.34M-31.76M
Change in Inventory00-1.35B-272.56K0000-241K-24.13M
Change in Payables1.31M1.87M-1.28M294.51K-297.16K-7.56M814K-1.15M2.33M1.92M
Cash from Investing-2.89M-2.54M-870.94K-1.85M247.91K-107K-587K-11.29M-8.44M-7.08M
Capital Expenditures-2.89M-2.54M-870.94K-1.85M-752.09K-107K-592K-1.29M-4.95M-3.59M
CapEx % of Revenue21.83%35.05%32.17%22.92%101.68%0.83%3.72%7.38%35.36%-
Acquisitions00001M05K000
Investments----------
Other Investing0000000-10M-3.49M-3.49M
Cash from Financing6.11M28.81M68.82M66.39M63.42M26.32M64.96M43.25M194.66M64.45M
Debt Issued (Net)5.66M30.12M-1.43M3.97M-6.77M-420K8.96M19.37M52.5M57M
Equity Issued (Net)001000K1000K1000K1000K1000K1000K1000K1.78M
Dividends Paid0000000000
Share Repurchases0000000000
Other Financing445.47K-1.3M-2.18M0-1.04M5.03M1.55M-363K3.61M3.91M
Net Change in Cash
-10.72M▲ 0%
1.98M▲ 118.5%
36.12M▲ 1723.8%
16.26M▼ 55.0%
9.52M▼ 41.5%
-7.82M▼ 182.2%
35.79M▲ 557.5%
-9.6M▼ 126.8%
92.8M▲ 1066.3%
-43.37M▲ 0%
Free Cash Flow
-16.83M▲ 0%
-26.83M▼ 59.4%
-32.7M▼ 21.9%
-50.13M▼ 53.3%
-54.9M▼ 9.5%
-34.14M▲ 37.8%
-29.18M▲ 14.5%
-42.85M▼ 46.9%
-98.37M▼ 129.5%
-107.83M▲ 0%
FCF Margin %-127.35%-369.72%-1208.04%-621.06%-7422.19%-265.63%-183.12%-245.05%-702.85%-155.79%
FCF Growth %--59.43%-21.86%-53.3%-9.5%37.81%14.53%-46.86%-129.55%-16.62%
FCF per Share-1.96-3.13-4.57-2.71-1.62-0.69-0.48-0.66-1.25-1.25
FCF Conversion (FCF/Net Income)0.88x0.83x0.60x1.01x0.91x0.98x0.70x0.53x0.72x0.88x
Interest Paid00000423K0000
Taxes Paid0000000000

LQDA Key Ratios

Liquidia Corporation (LQDA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20172018201920202021202220232024TTM
Return on Equity (ROE)--284.34%-177.43%-112.72%-50.72%-52.69%-114.01%-209.35%-552.55%
Return on Invested Capital (ROIC)----334.73%-108.41%-127.95%-316.75%-500.72%-500.72%
Gross Margin95.59%95.52%90%67.86%76.48%82.06%83.49%58%89.4%
Net Margin-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-176.04%
Debt / Equity-0.68x0.70x0.24x0.25x0.27x1.05x1.58x1.58x
Interest Coverage-2.15x-1.84x-34.09x-68.87x-44.35x-16.58x-11.70x-9.71x-4.63x
FCF Conversion0.83x0.60x1.01x0.91x0.98x0.70x0.53x0.72x0.88x
Revenue Growth-45.08%-62.7%198.2%-90.84%1637.77%23.98%9.75%-19.97%343.41%

LQDA SEC Filings & Documents

Liquidia Corporation (LQDA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 5, 2026·SEC

Material company update

Jan 9, 2026·SEC

Material company update

Nov 3, 2025·SEC

10-K Annual Reports

2
FY 2026

Mar 5, 2026·SEC

FY 2025

Mar 19, 2025·SEC

10-Q Quarterly Reports

4
FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 12, 2025·SEC

FY 2025

May 8, 2025·SEC

LQDA Frequently Asked Questions

Liquidia Corporation (LQDA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Liquidia Corporation (LQDA) reported $69.2M in revenue for fiscal year 2024. This represents a 424% increase from $13.2M in 2016.

Liquidia Corporation (LQDA) saw revenue decline by 20.0% over the past year.

Liquidia Corporation (LQDA) reported a net loss of $121.8M for fiscal year 2024.

Dividend & Returns

Liquidia Corporation (LQDA) has a return on equity (ROE) of -209.4%. Negative ROE indicates the company is unprofitable.

Liquidia Corporation (LQDA) had negative free cash flow of $107.8M in fiscal year 2024, likely due to heavy capital investments.

Explore More LQDA

Liquidia Corporation (LQDA) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.